Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
Add more filters










Publication year range
1.
Prostate Cancer Prostatic Dis ; 17(4): 315-9, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25224557

ABSTRACT

BACKGROUND: Controversial data on the association of single-nucleotide polymorphisms (SNPs, rs3787016G>A and rs10773338G>A) in long non-coding RNA (lncRNA) with prostate cancer risk were emerged. Considering possible genetic differences among populations, we conducted the present study to clarify these discrepancies and re-validate these results in an eastern Chinese population and thus provide clues for new therapeutic targets of prostate cancer. METHODS: Genotypes of these two SNPs from 1015 ethnic Han Chinese patients with prostate cancer and 1032 cancer-free controls were determined by Taqman assays. Logistic regression models were used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for risk associations. RESULTS: The association of rs3787016 A variant genotypes with a significantly higher prostate cancer risk were found (adjusted OR = 1.418, 95% CI = 1.090-1.844 for AA vs GG). Stratification analysis indicated that the risk of rs3787016 variant AG/AA genotypes was more evident in younger subjects, ever smoking, patients with Gleason score ⩾ 7(4+3) and highly aggressive status. All these risks were not present for rs10773338G>A. CONCLUSIONS: These findings suggested that lncRNA SNPs may contribute to prostate cancer risk in an eastern Chinese population. Larger and well-designed studies with different ethnic populations are warranted to validate our findings.


Subject(s)
Asian People/genetics , Genetic Predisposition to Disease/genetics , Polymorphism, Single Nucleotide/genetics , Prostatic Neoplasms/genetics , RNA, Long Noncoding/genetics , Adult , Aged , Aged, 80 and over , Genotype , Humans , Male , Middle Aged , Odds Ratio , Risk Factors
2.
J Phys Condens Matter ; 25(16): 165503, 2013 Apr 24.
Article in English | MEDLINE | ID: mdl-23553529

ABSTRACT

The 4f-5d excitation and emission spectra of Ce(3+) and Pr(3+) ions in Ca9Lu(PO4)7 as recently reported (2012 J. Phys.: Condens. Matter 24 385502) were further analyzed and simulated by employing the effective Hamiltonian model for the 4f(N) and 4f(N-1)5d electronic configurations of impurity lanthanide ions and the exchange charge model of crystal-field theory. The multi-site effect on the 4f-5d transition spectra was explicitly discussed from the points of view of the local structure and site occupation ratios of lanthanide ions in Ca9Lu(PO4)7. An excellent agreement between the predicted and measured spectra confirms the validity of the performed calculations. Based on these energy level and intensity calculation results, the radiative lifetimes of the 5d-4f emissions of Ce(3+) and Pr(3+) ions have been modeled to show nearly independent temperature trends. Comparison with the measured lifetimes suggests the nonradiative relaxation process in this host is probably related to the intrinsic defect states. In addition to the studies of the 4f-5d transitions, a general theoretical scheme to calculate the lowest 4f-6s transition energy of the Ce(3+) ion was proposed for the first time on the basis of the ligand polarization model. The predicted 6s energy position of the Ce(3+) ion in Ca9Lu(PO4)7 is solid evidence corroborating our previous spectroscopic assignment.


Subject(s)
Calcium Compounds/chemistry , Cerium/chemistry , Electrons , Lutetium/chemistry , Models, Molecular , Phosphates/chemistry , Praseodymium/chemistry , Crystallography, X-Ray , Molecular Conformation , Spectrophotometry, Ultraviolet , Vacuum
3.
J Phys Condens Matter ; 24(9): 095803, 2012 Mar 07.
Article in English | MEDLINE | ID: mdl-22322935

ABSTRACT

The results of high-pressure low-temperature optical measurements in a diamond-anvil cell of bulk gallium nitride crystals implanted with ytterbium are reported in combination with crystal field calculations of the Yb(3+) energy levels. Crystal field analysis of splitting of the (2)F(7/2) and (2)F(5/2) states has been performed, with the aim of assigning all features of the experimental luminescence spectra. A thorough analysis of the pressure behavior of the Yb(3+) luminescence lines in GaN allowed the determination of the ambient-pressure positions and pressure dependence of the Yb(3+) energy levels in the trigonal crystal field as well as the pressure-induced changes of the spin-orbit coupling coefficient.


Subject(s)
Electrons , Gallium/chemistry , Ytterbium/chemistry , Crystallization , Luminescence , Pressure , Temperature
4.
Andrologia ; 44 Suppl 1: 87-93, 2012 May.
Article in English | MEDLINE | ID: mdl-21729132

ABSTRACT

The aim of this study was to explore the effects and mechanisms of Icarisid II (ICA-II) on enhancing the cellular cGMP in rat corpus cavernosum tissue (RCCT). Diabetes mellitus Wistar rats were induced by streptozotocin, and diabetic ED rats were selected for the RCCT culture by apomorphine. ICA-II was extracted and purified from Icariin (ICA) by enzymatic method. The RCCT was treated with ICA-II, ICA and Sildenafil at different concentrations. cGMP and nitric oxide synthase (NOS) activities were checked respectively by enzyme immunoassay. Meanwhile, nNOS, iNOS and eNOS in RCCT were checked by western blot. ICA-II evaluated the intracellular cGMP to 8.01 ± 1.02 pmol mg(-1) min(-1), which is much weaker than that from Sildenafil (12.4 ± 1.16 pmol mg(-1) min(-1)) (P < 0.05). There is no significant difference between ICA-II and ICA. With the treatment of 10 µm ICA-II for 24 and 48 h, nNOS expression was significantly increased in RCCT (P < 0.05), while the eNOS expression level was very low without any change. Notably, ICA-II increased the intracellular NOS activity significantly in vitro in RCCT. Except the PDE5 inhibitory effect, ICA-II increases the intracellular cGMP through the enhancement of nNOS expression and NOS activity in RCCT in vitro. ICA-II implies a potential compound for neurogenic erectile dysfunction by NO-cGMP pathway.


Subject(s)
Cyclic GMP/metabolism , Cyclic Nucleotide Phosphodiesterases, Type 5/drug effects , Diabetes Complications/metabolism , Epimedium/chemistry , Erectile Dysfunction/metabolism , Flavonoids/pharmacology , Nitric Oxide Synthase/metabolism , Phosphodiesterase Inhibitors/pharmacology , Animals , Flavonoids/isolation & purification , Male , Rats , Rats, Wistar
7.
Acta Pharmacol Sin ; 21(12): 1153-6, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11603292

ABSTRACT

AIM: To study the protective effects of Ginkgo biloba extract (GbE) on gastric mucosa. METHODS: By means of restaint-cold stress (RCS) in rats and 100% ethanol gavage in mice, the index of gastric mucosal injury was evaluated. The gastric juice was collected using pyloric ligation, and the volume and acidity of juice, and activity of pepsin were determined. The content of malondialdehyde (MDA) was measured by thiobarbituric acid (TBA) method. RESULTS: GbE (25, 50, and 100 mg/kg, bid x 5 d, ig) inhibited dose-dependently the gastric mucosal injury induced by RCS and 100% ethanol gavage. The index of gastric mucosal injury after RCS in groups pretreated with GbE was 58%, 43%, and 31% of control group respectively. The index of gastric mucosal injury induced by ethanol in groups pretreated with GbE was 62%, 36%, and 26% of the control group, respectively. And GbE enhanced the protective effects of cimetidine (Cim) on gastric mucosa. But it did not obviously influence the volume and acidity of gastric juice as well as the activity of pepsin. One hour after the administration of ig 100% ethanol, the contents of MDA in gastric mucosa and serum in mice increased (P < 0.01) vs the control group. But pretreatment with GbE (25, 50, and 100 mg/kg, ig) could inhibit this increase of MDA both in gastric mucosa and in serum. CONCLUSION: GbE had protective effects on gastric mucosa and GbE plus Cim possessed the synergism in the treatment of acute gastric mucosal lesions.


Subject(s)
Drugs, Chinese Herbal/pharmacology , Gastric Mucosa/pathology , Ginkgo biloba , Stomach Ulcer/pathology , Animals , Anti-Ulcer Agents/pharmacology , Cimetidine/pharmacology , Drug Synergism , Female , Gastric Juice/metabolism , Gastric Mucosa/metabolism , Ginkgo biloba/chemistry , Male , Malondialdehyde/blood , Malondialdehyde/metabolism , Mice , Pepsin A/metabolism , Rats , Rats, Wistar , Stomach Ulcer/etiology , Stomach Ulcer/metabolism , Stress, Physiological/complications
8.
Zhongguo Yao Li Xue Bao ; 20(1): 27-30, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10437120

ABSTRACT

AIM: To study the effects of hyperin (Hyp) on free intracellular calcium concentration ([Ca2+]i) of brain cells. METHODS: The neonatal rat brain cells were dissociated. [Ca2+]i in presence and absence of extracellular high K+, L-glutamic acid (Glu), 5-hydroxytryptamine (5-HT), and norepinephrine (NE) were assayed with Fura 2-AM. RESULTS: The resting [Ca2+]i in Hanks' solution (CaCl2 1.3 mmol.L-1) was (208 +/- 12) nmol.L-1 (n = 17). Hyp had no significant effects on the resting [Ca2+]i. Hyp 1.0, 4.0, and 16.0 mumol.L-1 markedly inhibited the increase of [Ca2+]i evoked by K+ 50 mmol.L-1 in a concentration-dependent manner. Hyp 16.0 mumol.L-1 inhibited the increases of [Ca2+]i induced by NE 1, 2, 4, and 8 mumol.L-1. Hyp (16.0 mumol.L-1) also markedly attenuated 5-HT and Glu-induced increase of [Ca2+]i. CONCLUSION: Hyp possessed inhibitory effects on influx of Ca2+ in the neonatal rat brain cells.


Subject(s)
Brain/metabolism , Calcium Channel Blockers/pharmacology , Calcium/metabolism , Quercetin/analogs & derivatives , Animals , Animals, Newborn , Biological Transport, Active , Brain/cytology , Cell Separation , Norepinephrine/antagonists & inhibitors , Quercetin/pharmacology , Rats , Rats, Sprague-Dawley , Sodium Glutamate/antagonists & inhibitors
9.
Clin Immunol Immunopathol ; 89(3): 196-204, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9837689

ABSTRACT

Tolerance to experimental autoimmune myasthenia gravis by nasal administration of microgram amounts of acetylcholine receptor (AChR) has been reported. To elucidate the mechanisms behind tolerance induction via the respiratory tract and the involvement of CD4(+) T cells, we established AChR-specific CD4(+)CD8(-) T cell clones from nasally tolerized rats. Nasal tolerance decreased leukocyte function-associated antigen-1 (LFA-1) expression in CD4(+) T cells from tolerized rats. There was no difference between nasally tolerized and control rats in expression of intercellular adhesion molecule-1. The levels of transforming growth factor-beta (TGF-beta) mRNA-expressing cells were upregulated in CD4(+) T cell clones after tolerance induction. These findings suggest that decreased LFA-1 expression in CD4(+) T cells contributes to reduction of the infiltration of inflammatory CD4(+) T cells, while upregulated TGF-beta may inhibit lymphocyte functions.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , Lymphocyte Function-Associated Antigen-1/metabolism , Myasthenia Gravis/immunology , Myasthenia Gravis/metabolism , Receptors, Cholinergic/immunology , Transforming Growth Factor beta/genetics , Administration, Intranasal , Animals , Autoantigens/administration & dosage , Clone Cells , Cytokines/genetics , Disease Models, Animal , Down-Regulation , Female , Intercellular Adhesion Molecule-1/metabolism , Muscle, Skeletal/immunology , Muscle, Skeletal/metabolism , Muscle, Skeletal/pathology , Myasthenia Gravis/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Inbred Lew , Self Tolerance , Up-Regulation
10.
Eur J Immunol ; 26(11): 2552-8, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8921938

ABSTRACT

Various mouse and rat strains show different susceptibilities to experimental autoimmune myasthenia gravis (EAMG) that can be induced by immunization with acetylcholine receptor (AChR) and Freund's complete adjuvant, and represents a model for the antibody-mediated myasthenia gravis in humans. We examined AChR-induced B and T cell responses and cytokine mRNA expression to study the mechanisms behind susceptibility to EAMG in Lewis rats and resistance in Wistar Furth (WF) rats. Both strains had similarly elevated concentrations and affinities of serum anti-AChR antibodies, and no difference between the two strains for frequencies of cells in lymphoid organs expressing mRNA of the B cell stimulating cytokine interleukin-4 was found. In contrast, T cell responses to AChR measured by proliferation and by enumeration of interferon-gamma-expressing cells at both mRNA and protein level were lower in the resistant WF rats. This strain showed, instead, an up-regulation of the anti-inflammatory transforming growth factor-beta. Strain-related differences in the susceptibility to actively induced EAMG are thus related to quantitative differences in distribution between pro-inflammatory and anti-inflammatory cytokines.


Subject(s)
Autoantigens/immunology , Cytokines/biosynthesis , Cytokines/genetics , Myasthenia Gravis/chemically induced , Myasthenia Gravis/immunology , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Animals , Antibody Affinity/immunology , Autoantibodies/biosynthesis , Autoantibodies/immunology , Base Sequence , Female , Immunity, Innate , In Situ Hybridization , Interferon-gamma/biosynthesis , Interferon-gamma/genetics , Interleukin-4/biosynthesis , Interleukin-4/genetics , Lymphocyte Activation , Molecular Sequence Data , RNA, Messenger/analysis , Rats , Rats, Inbred Lew , Rats, Inbred WF , Receptors, Cholinergic/immunology , Transforming Growth Factor beta/biosynthesis , Transforming Growth Factor beta/genetics
11.
J Neurol Sci ; 142(1-2): 114-20, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8902730

ABSTRACT

Nitric oxide (NO) may be involved in myelin and oligodendrocyte injury associated with multiple sclerosis (MS), a demyelinating disease of unknown etiology. The cerebrospinal fluid (CSF) from MS patients may provide an important signal inducing a pathologic process within the central nervous system (CNS). To investigate this question, CSF-induced NO production by glial cells was studied in 38 patients with multiple sclerosis (MS), 30 patients with other CNS inflammatory diseases (ID) and 20 with tension headache (TH) as control. Neuron damage was estimated by release of lactate dehydrogenase (LDH), whereas oligodendrocyte damage was estimated by a percentage of viable cells in primary oligodendrocyte cultures. Here we show that CSFs from 13/38 (34%) patients with MS stimulate glial cells to produce NO, compared to 2/20 (10%) of patients with ID and 1/30 (3%) with tension headache. The levels of NO production correlated positively with the amounts of LDH released and negatively with percentage of viable oligodendrocytes, suggesting that NO may represent a mechanism for oligodendrocyte losses in affected tissues and play a role in lesion formation in MS and its animal model experimental allergic encephalomyelitis (EAE).


Subject(s)
Cerebrospinal Fluid Proteins/pharmacology , Multiple Sclerosis/cerebrospinal fluid , Neurons/drug effects , Nitric Oxide/metabolism , Oligodendroglia/drug effects , Animals , Cells, Cultured/drug effects , Cells, Cultured/metabolism , Cerebral Cortex/cytology , Humans , L-Lactate Dehydrogenase/metabolism , Neurons/enzymology , Nitric Oxide/biosynthesis , Oligodendroglia/metabolism , Rats , Rats, Inbred Lew , Time Factors
12.
Zhongguo Yao Li Xue Bao ; 17(4): 341-4, 1996 Jul.
Article in English | MEDLINE | ID: mdl-9812719

ABSTRACT

AIM: To study the protective and antiperoxidative effects of hyperin (hyperoside; quercetin-3-O-galactoside; Hyp) on myocardial ischemia/reperfusion. METHODS: The rabbit anterior descenging branch of left coronary artery was occluded for 60 min and then released to allow reperfusion for 20 min. Hemodynamics (LVP, LV +/- dp/dt) and electrocardiogram (ECG, lead II) were monitored continuously with polygraph. After reperfusion, the blood sample and myocardium were taken to assay plasma creatine phosphokinase (CPK), lactate dehydrogenase (LDH), and cations in myocardium. Using a Langendorff system, the isolated heart of rat was initiated by ischemia for 40 min followed by 30 min of reperfusion. Malondialdehyde (MDA) contents of cardiac effluent and myocardium were measured with fluorescence spectrophotometer. RESULTS: Hyp 10 mg.kg-1 i.v. depressed changes in LVP, LV +/- dp/dtmax, ECG, plasma CPK, LDH, and cations (Ca2+, Mg2+, Na+) in myocardium induced by ischemia/reperfusion in rabbits. Hyp 10 and 100 mumol.L-1 markedly reduced the increase in MDA production in isolated rat hearts after ischemia/reperfusion. CONCLUSION: Hyp possesses a protective effect against myocardial ischemia/reperfusion injury via attenuating lipid peroxidation.


Subject(s)
Calcium Channel Blockers/pharmacology , Myocardial Reperfusion Injury/metabolism , Quercetin/analogs & derivatives , Animals , Creatine Kinase/blood , Female , Hemodynamics/drug effects , L-Lactate Dehydrogenase/blood , Male , Malondialdehyde/metabolism , Myocardial Reperfusion Injury/physiopathology , Myocardium/metabolism , Quercetin/pharmacology , Rabbits , Rats , Rats, Wistar
13.
Clin Exp Immunol ; 104(3): 509-16, 1996 Jun.
Article in English | MEDLINE | ID: mdl-9099937

ABSTRACT

Nasal administration of nicotinic acetylcholine receptor (AChR) to Lewis rats prior to myasthenogenic immunization with AChR plus Freund's complete adjuvant (FCA) resulted in prevention or marked decrease of the severity of EAMG, suppression of AChR-specific B cell responses and of AChR-reactive T cell functions. To examine the involvement of immunoregulatory cytokines and the underlying mechanisms involved in tolerance induction, in situ hybridization with radio-labelled synthetic oligonucleotide probes was adopted to enumerate mononuclear cells (MNC) expressing mRNA for the proinflammatory cytokine IFN-gamma, the B cell stimulating IL-4 and the immune response-down-regulating TGF-beta. Popliteal and inguinal lymph nodes from EAMG rats contained elevated numbers of AChR-reactive IFN-gamma, IL-4 and TGF-beta mRNA-expressing cells compared with control rats receiving PBS nasally and injected with FCA only. Nasal tolerance to EAMG was accompanied by decreased numbers of AChR-reactive IFN-gamma and IL-4 mRNA-expressing cells, and strong up-regulation of TGF-beta mRNA-positive cells in lymphoid organs compared with non-tolerized EAMG control rats. The relative affinity of anti-AChR antibodies was lower, but muscle AChR amounts were higher in nasally tolerized rats compared with non-tolerized EAMG control rats. The results suggest that IFN-gamma and IL-4 are central effector molecules in the development of EAMG, and that TGF-beta plays an important role in tolerance induction to EAMG.


Subject(s)
Immune Tolerance , Interferon-gamma/metabolism , Interleukin-4/metabolism , Leukocytes, Mononuclear/immunology , Myasthenia Gravis/immunology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Transforming Growth Factor beta/metabolism , Administration, Intranasal , Animals , Concanavalin A/immunology , DNA Probes/genetics , Electrophoresis, Polyacrylamide Gel , Female , Immunoglobulin G/analysis , Immunoglobulin G/immunology , In Situ Hybridization , Interferon-gamma/genetics , Interleukin-4/genetics , Lymph Nodes/cytology , Lymph Nodes/immunology , Lymph Nodes/metabolism , Muscles/cytology , Muscles/immunology , Muscles/metabolism , Myelin Basic Protein/immunology , Oligonucleotides/genetics , Rats , Rats, Inbred Lew , Receptors, Nicotinic/immunology , Transforming Growth Factor beta/genetics , Up-Regulation , Vaccination
14.
Clin Exp Immunol ; 103(3): 475-81, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8608649

ABSTRACT

We utilized a model of myelin basic protein (MBP) activation in vivo and MBP-stimulated cultures in vitro to study the influence of TGF-beta1 on glial cell proliferation and ICAM-1/leucocyte function-associated antigen-1 (LFA-1) expression, and to observe the antagonistic effects of TGF-beta1 and IFN-gamma. TGF-beta1 inhibited MBP-stimulated and MBP-activated glial cell proliferation, especially in MBP-stimulated separated microglia and astrocytes, and down-regulated the expression of ICAM-1 on MBP-stimulated glial cells and separated microglia. ICAM-1 expression on MBP-activated glial cells was intensely suppressed, whereas its expression on MBP-stimulated astrocytes was not influenced. TGF-beta1 had no effect on LFA-1 expression. In contrast, IFN-gamma up-regulated ICAM-1 expression, but inhibited proliferative response on MBP-stimulated glial cells when cultured without TGF-beta1. Examination of TGF-beta1 and IFN-gamma interactions revealed that TGF-beta1-mediated inhibition of proliferation and down-regulation of ICAM-1 on glial cells were prevented by IFN-gamma. The suppressive effect was re-established with high doses of TGF-beta1 in cultures, indicating that biological effects of TGF-beta1 vary depending on nitric oxide (NO) production, its concentration in the microenvironment and regulation of the cytokine network.


Subject(s)
Intercellular Adhesion Molecule-1/metabolism , Interferon-gamma/pharmacology , Neuroglia/cytology , Neuroglia/physiology , Transforming Growth Factor beta/antagonists & inhibitors , Transforming Growth Factor beta/pharmacology , Animals , Cell Division/drug effects , Cells, Cultured , Central Nervous System/physiology , Down-Regulation/drug effects , Drug Interactions , Intercellular Adhesion Molecule-1/biosynthesis , Intercellular Adhesion Molecule-1/physiology , Lymphocyte Function-Associated Antigen-1/biosynthesis , Male , Neuroglia/metabolism , Rats , Rats, Inbred Strains , Recombinant Proteins
15.
Ann N Y Acad Sci ; 778: 273-87, 1996 Feb 13.
Article in English | MEDLINE | ID: mdl-8610980

ABSTRACT

Oral and nasal administration of nicotinic acetylcholine receptor (AChR) to Lewis rats prior to myasthenogenic immunization with AChR and complete Freund's adjuvant (CFA) resulted in prevention or marked decrease of the severity of experimental autoimmune myasthenia gravis (EAMG) and suppression of AChR-specific B-cell responses and of AChR-reactive T-cell function. To examine the involvement of immunoregulatory cytokines and the underlying mechanisms involved in tolerance induction, in situ hybridization with radiolabeled cDNA oligonucleotide proves was adopted to enumerate mononuclear cells (MNC) expressing mRNA for the proinflammatory cytokine interferon-gamma (IFN-gamma), the B cell-stimulating interleukin-4 (IL-4), and the immunosuppressive transforming growth factor-beta (TGF-beta). Popliteal and inguinal lymph nodes from EAMG rats contained elevated numbers of AChR-reactive IFN-gamma, IL-4, and TGF-beta mRNA-expressing cells, compared to control rats receiving PBS orally or nasally and injected with CFA only. Oral and nasal tolerance was accompanied by decreased numbers of AChR-reactive IFN-gamma and IL-4 mRNA-expressing cells and strong up-regulation of TGF-beta mRNA-positive cells in lymphoid organs when compared to nontolerized EAMG control rats. The results suggest that IFN-gamma and IL-4 are central effector molecules in the development of EAMG and that TGF-beta plays an important role in tolerance induction to EAMG.


Subject(s)
Antigens/immunology , Immune Tolerance , Interferon-gamma/biosynthesis , Intestinal Mucosa/immunology , Myasthenia Gravis/immunology , Receptors, Cholinergic/immunology , T-Lymphocyte Subsets/immunology , Transforming Growth Factor beta/biosynthesis , Administration, Intranasal , Administration, Oral , Animals , Antibody Formation , Antigens/administration & dosage , Disease Models, Animal , Down-Regulation , Female , Gene Expression , Humans , Interleukin-4/biosynthesis , Monocytes/immunology , Muscle, Skeletal/metabolism , Myasthenia Gravis/metabolism , RNA, Messenger/biosynthesis , Rats , Rats, Inbred Lew , Receptors, Cholinergic/biosynthesis , Time Factors
16.
Scand J Immunol ; 42(4): 457-65, 1995 Oct.
Article in English | MEDLINE | ID: mdl-7569779

ABSTRACT

CD8+ T cells can perform both Th1- and Th2-like functions by producing cytokines such as interferon-gamma (IFN-gamma) and interleukin-4 (IL-4), as well as the immune response down-regulating transforming growth factor-beta (TGF-beta), which are all involved in the development of experimental autoimmune myasthenia gravis (EAMG), a model for human MG. We have reported that depletion of CD8+ T cells results in the suppression of EAMG accompanied by the down-regulation of AChR-specific B cell responses and AChR-reactive IFN-gamma secreting Th1-like cells. To identify the involvement of IFN-gamma, IL-4 and TGF-beta in the development of EAMG after CD8+ T cell depletion, the expression of mRNA for these cytokines was studied in mononuclear cells from popliteal, inguinal and mesenteric lymph nodes, spleen and thymus by adopting in situ hybridization with complementary DNA oligonucleotide probes. Depletion of CD8+ T cells resulted in decreased levels of IFN-gamma and IL-4 mRNA expressing cells in different lymphoid organs except thymus, but no change in the numbers of TGF-beta mRNA expressing cells. The results imply that the suppression of EAMG after depletion of CD8+ T cells is caused by decreasing the effector factors but not by increasing the suppressor factor(s).


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Interferon-gamma/biosynthesis , Interleukin-4/biosynthesis , Myasthenia Gravis/immunology , Animals , Autoimmunity , CD8-Positive T-Lymphocytes/pathology , Cell Count , Disease Models, Animal , Down-Regulation , Female , Immunophenotyping , Lymphoid Tissue/immunology , Lymphoid Tissue/metabolism , Lymphoid Tissue/pathology , Myasthenia Gravis/pathology , RNA, Messenger/analysis , Rats , Rats, Inbred Lew , Transforming Growth Factor beta/biosynthesis
17.
Eur J Immunol ; 25(5): 1191-8, 1995 May.
Article in English | MEDLINE | ID: mdl-7774622

ABSTRACT

To understand the role of CD8+ T cells in experimental autoimmune myasthenia gravis (EAMG), CD8+ T cells were depleted by injecting a monoclonal anti-rat CD8 antibody (OX8) into Lewis rats immunized with Torpedo acetylcholine receptor (AChR) in complete Freund's adjuvant (CFA). CD8-depleted EAMG rats showed strikingly less muscle weakness and lower anti-AChR IgG antibody levels compared to Hy2-15-injected control EAMG rats. Moreover, the numbers of AChR-specific IgG antibody-secreting cells, AChR-reactive interferon-gamma-secreting T helper type 1-like cells and lymphocyte proliferation to AChR were lower in the CD8-depleted group than in control EAMG rats. These differences were significant among mononuclear cells from inguinal and popliteal lymph nodes, mesenteric lymph nodes and spleen, but not from thymus when examined 3, 5 and 7 weeks post-immunization. We suggest that CD8+ T cells are involved in the induction and persistance of EAMG by directly or indirectly affecting AChR-reactive T cells and anti-AChR IgG antibody-secreting cells.


Subject(s)
Autoimmune Diseases/prevention & control , CD8-Positive T-Lymphocytes/immunology , Immune Tolerance , Myasthenia Gravis/prevention & control , Animals , Antibodies, Monoclonal/pharmacology , Autoimmune Diseases/immunology , Female , Hypersensitivity, Delayed/immunology , Immunization , Immunoglobulin G/biosynthesis , Immunoglobulin G/immunology , Interferon-gamma/metabolism , Lymphocyte Activation , Lymphocyte Count , Lymphoid Tissue/immunology , Lymphoid Tissue/pathology , Muscles/physiopathology , Myasthenia Gravis/immunology , Rats , Rats, Inbred Lew , Receptors, Cholinergic/immunology , Th1 Cells/immunology , Torpedo
18.
J Neuroimmunol ; 58(1): 51-60, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7537280

ABSTRACT

Experimental autoimmune myasthenia gravis (EAMG) is a well established animal model, which can be induced in various animal species and strains with acetylcholine receptor (AChR) and represents an experimental counterpart of human myasthenia gravis (MG). Current immunotherapies of both EAMG and MG are non-specific and limited by their toxicity. Tolerance to EAMG has been achieved by oral administration of milligram quantities of Torpedo AChR. In the present report we demonstrate that nasal administration of microgram doses of Torpedo AChR to female Lewis rats prior to immunization with Torpedo AChR and complete Freund's adjuvant resulted in the prevention of subsequently induced EAMG, the suppression of serum anti-AChR antibody levels, the decrease of delayed-type hypersensitivity responses to AChR, as well as the suppression of AChR-specific immunoglobulin G-secreting cells, AChR-reactive interferon-gamma-secreting cells and T cell proliferation in peripheral lymphoid organs, particularly in popliteal and inguinal lymph nodes regional to immunization. We conclude that clinical signs of EAMG can be efficiently prevented by nasal administration of AChR in parallel with the downregulation of both B and T cell responses specific to AChR.


Subject(s)
Interferon-gamma/biosynthesis , Myasthenia Gravis/immunology , Receptors, Cholinergic/immunology , Administration, Intranasal , Animals , Concanavalin A , Electric Organ/metabolism , Enzyme-Linked Immunosorbent Assay , Female , Hypersensitivity, Delayed , Immunoglobulin G/biosynthesis , Lymphocyte Activation , Myasthenia Gravis/physiopathology , Myasthenia Gravis/prevention & control , Myelin Basic Protein/immunology , Rats , Rats, Inbred Lew , Receptors, Cholinergic/isolation & purification , Time Factors , Torpedo
19.
Yao Xue Xue Bao ; 29(1): 15-9, 1994.
Article in Chinese | MEDLINE | ID: mdl-8036895

ABSTRACT

Hyperin(Hyp) was shown to inhibit the positive inotropic action of calcium ion on the isolated papillary muscles and shift the dose response curve of calcium ion to the right. As a plot lg(x-1) vs -lg(B) resulted in straight lines with slopes of -0.625. On the action potentials of guinea pig myocardial cells, Hyp markedly decreased the duration of plateau of action potentials (APD20%) but did not influence the APD100%, RP, APA, OS and Vmax. In the atrium preparations of mice, Hyp significantly inhibited influx of 45Ca induced by high K+. All findings indicate that Hyp can inhibit the inward flow of calcium ion.


Subject(s)
Calcium Channel Blockers/pharmacology , Calcium Channels/drug effects , Myocardial Contraction/drug effects , Quercetin/analogs & derivatives , Action Potentials/drug effects , Animals , Calcium Chloride/antagonists & inhibitors , Dose-Response Relationship, Drug , Guinea Pigs , In Vitro Techniques , Membrane Potentials/drug effects , Quercetin/pharmacology , Rabbits , Stimulation, Chemical , Verapamil/pharmacology
20.
Yao Xue Xue Bao ; 24(5): 326-30, 1989.
Article in Chinese | MEDLINE | ID: mdl-2609966

ABSTRACT

In previous works, we reported that Hyp (hyperin) showed strong analgesic effect, and inhibited discharges induced by multianalgesics, but without anesthetic action. In this study, the analgesic mechanism of Hyp was further investigated. In the tail-flick test in mice, EGTA was shown to markedly enhance the analgesic effect of Hyp and shift the dose-effect curve to the upper-left. CaCl2 significantly antagonized the effect of Hyp and shifted the dose-effect curve to the lower-right. In the afferent discharges induced by analgesics, EGTA markly elevated while cacl2 lowered the effect of Hyp. It was also found that A23187, which promote influx of Ca2+, could antagonize the effect of Hyp. In the frog sciatic nerves, we found that Hyp could significantly inhibit influx of Ca2+. This finding suggests that the analgesic effect of Hyp may have close relationship with the reduction of calcium in afferent nerve endings.


Subject(s)
Analgesics , Flavonoids/pharmacology , Quercetin/pharmacology , Animals , Anura , Calcium/metabolism , Electrophysiology , Female , Male , Mice , Pain/physiopathology , Quercetin/analogs & derivatives , Rabbits , Sciatic Nerve/metabolism , Sensory Thresholds/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...